Vincent Paul Liptak Buys 2,200 Shares of BlossomHill Therapeutics (NASDAQ:BLSM) Stock

BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) General Counsel Vincent Paul Liptak acquired 2,200 shares of BlossomHill Therapeutics stock in a transaction that occurred on Monday, August 10th. The stock was purchased at an average cost of $16.00 per share, with a total value of $35,200.00. Following the completion of the purchase, the general counsel owned 111,412 shares in the company, valued at $1,782,592. The trade was a 2.01% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Vincent Paul Liptak also recently made the following trade(s):

• On Friday, August 7th, Vincent Paul Liptak acquired 2,500 shares of BlossomHill Therapeutics stock. The stock was purchased at an average price of $15.80 per share, for a total transaction of $39,500.00.

BlossomHill Therapeutics Stock Performance

Shares of BLSM opened at $16.52 on Wednesday. BlossomHill Therapeutics, Inc. has a 52-week low of $15.25 and a 52-week high of $17.25.